title: [Cervical cancer: particularities in HIV patients].
abstract: Cervical cancer is the second most common cancer in women worldwide. It represents one of the most challenging public health problems in developing countries. HIV-infected women have a higher risk of cervical cancer which is an AIDS defining cancer. Cervical cancer treatment in HIV-infected and non-infected women is the same. HIV naive women must be prescribed combination antiretroviral therapy at the moment of HIV cancer diagnosis. A close collaboration between oncologist and infectiologist is mandatory to optimize HIV treatment. Among HIV-infected women, PAP-smear screening for early detection and treatment of precancerous cervical lesions is recommended. HPV vaccination is also recommended with the same efficacy and safety profile as the general population.
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de cancérologie-radiothérapie, 1, avenue Claude-Vellefaux, 75010 Paris, France.
authors.forename: Noémie
authors.initials: N
authors.lastname: Grellier
authors.affiliation: AP-HP, Hôpital Saint-Louis, Service de cancérologie-radiothérapie, 1, avenue Claude-Vellefaux, 75010 Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Quéro
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D055088:Early Detection of Cancer; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D065006:Papanicolaou Test; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D014626:Vaginal Smears
chemical_list: D019380:Anti-HIV Agents; D053918:Papillomavirus Vaccines
keywords: HIV; cancer; cervical; review